166 filings
Page 7 of 9
6-K
cmcrmjuqy
8 Sep 16
Galmed Pharmaceuticals Announces the Appointment of Dr. Liat Hayardeny, Ph.D. MBA, as Chief Scientific Officer
12:00am
6-K
q5j99 35420f9
3 Aug 16
Galmed Pharmaceuticals Reports Second Quarter 2016Financial Results and Provides Business Update
12:00am
6-K
7hm7x mwnp
1 Aug 16
Galmed Pharmaceuticals Announces the Appointment of
12:00am
6-K
ha22 7iekzapwqh9eyk
28 Jul 16
Galmed Pharmaceuticals and SAMIL Pharm Sign a License Agreement for the Commercialization of AramcholTM in Korea
12:00am
6-K
yb2wdpqwi07jvy4mtmj5
30 Jun 16
Galmed Pharmaceuticals and Weizmann Institute of Science to enter a research collaboration agreement to assess AramcholTM effects on microbiome
12:00am
6-K
7g5rfqkofq qlvb2bi
7 Jun 16
Current report (foreign)
12:00am
6-K
o1ivg 5rr5xk
1 Jun 16
Current report (foreign)
12:00am
6-K
hs5lch43
1 Jun 16
Current report (foreign)
12:00am
6-K
cs465n58z8cprsr3xpt
26 May 16
Current report (foreign)
12:00am
6-K
i0o5ggu3x iuw
16 May 16
Galmed Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Business Update
12:00am
6-K
eztg jrutgfvldg1q4vi
3 May 16
Current report (foreign)
12:00am
6-K
cuqo 3utqcpsaz
20 Apr 16
Current report (foreign)
12:00am
6-K
jz5b446 rsvzm8r
30 Mar 16
Current report (foreign)
12:00am
6-K
ae54n29p c69hoync
22 Mar 16
Galmed Pharmaceuticals Reports Full Year 2015 Financial Results and Provides Business Update
12:00am
6-K
dxyzbw uzjr
1 Mar 16
Galmed Pharmaceuticals Announces the Enrollment of the First Patient in the ARRIVE Study
12:00am
6-K
ouo6kzsaf z3uy
11 Feb 16
Galmed Pharmaceuticals Announces Retirement of Chief Medical Officer
12:00am
6-K
egd4di rm3
9 Nov 15
Galmed Pharmaceuticals Announces Commencement of
12:00am
6-K
j95gtlky56 r9scububi
13 Aug 15
Current report (foreign)
12:00am
6-K
m3bbnalm684110y dge
8 Jul 15
Galmed Pharmaceuticals Unfolds the Development of AramcholTM Non-Invasive Companion Diagnostic Program
12:00am
6-K
477pdcyxmvnd
15 May 15
Current report (foreign)
12:00am